Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion type Assertion NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_head.
- NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion description "[Twelve of these genes (RASSF1A, p16(INK4A), TSHR, MGMT, DAPK, ERalpha, ERbeta, RARbeta, PTEN, CD26, SLC5A8, and UCHL1) were frequently methylated in UTC (15%-86%) and thyroid cancer cell lines (25%-100%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_provenance.
- NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion evidence source_evidence_literature NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_provenance.
- NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion SIO_000772 16889486 NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_provenance.
- NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion wasDerivedFrom befree-2016 NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_provenance.
- NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_assertion wasGeneratedBy ECO_0000203 NP562854.RA6vEWVvg29wdIcFUHrLRhT0_X6dCiES0UmdpJ-rmj1EE130_provenance.